Lyell Immunopharma (LYEL)
(Delayed Data from NSDQ)
$10.98 USD
-0.34 (-3.00%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $10.85 -0.13 (-1.18%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LYEL 10.98 -0.34(-3.00%)
Will LYEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LYEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LYEL
Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why
After Plunging -37.9% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
LYEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -31.22% in 4 Weeks, Here's Why the Trend Might Reverse for Lyell Immunopharma (LYEL)
Down -30.89% in 4 Weeks, Here's Why Lyell Immunopharma (LYEL) Looks Ripe for a Turnaround
Lyell Immunopharma (LYEL) Upgraded to Buy: Here's What You Should Know
Other News for LYEL
12 Health Care Stocks Moving In Thursday's After-Market Session
Lyell Immunopharma (LYEL) Secures $100M Private Placement to Fund Clinical Milestones | LYEL ...
Lyell Immunopharma announces up to $100 million equity private placement
Lyell Immunopharma Announces up to $100 Million Equity Private Placement | LYEL Stock News
Lyell Immunopharma announces up to $100M equity private placement